University of Alabama, Birmingham (UAB) is a clinical research site located in Birmingham, Alabama, United States 35294.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Alabama, Birmingham (UAB) has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Alpha 1-Antitrypsin Deficiency, Emphysema, COPD.
Sponsors: Mereo BioPharma, Centers for Disease Control and Prevention, Hutchmed.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Alabama, Birmingham (UAB) has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama, Birmingham (UAB) has 4 clinical trials on record, with 1 currently active. Their work covers Alpha 1-Antitrypsin Deficiency, Emphysema, COPD.
Yes — University of Alabama, Birmingham (UAB) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.